Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Learn about ways to earn money quickly and reliably that can help you get started on your financial journey. Explore trustworthy options today.
28,655 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Markets staged a broad reversal as crude collapsed and investors priced in a potential de-escalation in a tense geopo...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
Nebius Group stock rocketing has traders buzzing. This guide breaks down the momentum, explains the drivers, and offe...
A veteran market analyst argues that military drones, not consumer EVs, may drive the next leap in battery technology...
Civilians in the Black Sea peninsula face fuel shortages as russia-occupied crimea halts gas sales amid intensified U...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
A 71-year-old retiree starts with $1.5M, planned $60K annual withdrawals, and ends up with $1.1M after three rough ma...
As AI tax prep tools surge this season, experts warn that convenience can come with risky gaps. taxpayers weigh speed...
VanEck's NLR ETF blends uranium miners, enrichers and reactor operators, trading at 0.61%, as investors seek a balanc...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...
Canoo has begun production of its electric vans, but internal documents show missing parts and late payments that cou...